Get the Stockscreener App
245.00
0.20%
0.49
After Hours:
245.00
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Quest Diagnostics Inc stock is traded at $245.00, with a volume of 811.00K.
It is up +0.20% in the last 24 hours and up +7.52% over the past month.
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 97% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,400 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.
See More
Previous Close:
$244.51
Open:
$244.11
24h Volume:
811.00K
Relative Volume:
0.89
Market Cap:
$27.04B
Revenue:
$11.28B
Net Income/Loss:
$1.07B
P/E Ratio:
27.02
EPS:
9.0657
Net Cash Flow:
$1.33B
1W Performance:
+1.34%
1M Performance:
+7.52%
6M Performance:
+16.06%
1Y Performance:
+35.84%
1-Day Range:
$243.49
$246.00
1-Week Range:
$237.53
$246.00
52-Week Range:
$171.18
$246.00
Quest Diagnostics Inc Stock (DGX) Company Profile
Name
Quest Diagnostics Inc
Sector
Industry
Phone
(973) 520-2700
Address
500 PLAZA DRIVE, SECAUCUS
Compare DGX vs TMO, DHR, NTRA, A, IDXX
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DGX
Quest Diagnostics Inc
|
245.00 | 26.63B | 11.28B | 1.07B | 1.33B | 9.0657 |
TMO
Thermo Fisher Scientific Inc
|
633.71 | 232.03B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
215.36 | 151.78B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
338.45 | 46.82B | 2.50B | -226.32M | 71.51M | -1.6412 |
A
Agilent Technologies Inc
|
155.08 | 44.14B | 7.23B | 1.41B | 1.09B | 4.979 |
IDXX
Idexx Laboratories Inc
|
553.44 | 43.00B | 4.45B | 1.10B | 1.06B | 13.59 |
Quest Diagnostics Inc Stock (DGX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-30-26 | Upgrade | Barclays | Equal Weight → Overweight |
| Aug-25-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Apr-02-25 | Initiated | Redburn Atlantic | Buy |
| Mar-04-25 | Downgrade | Citigroup | Buy → Neutral |
| Jan-06-25 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Dec-17-24 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Dec-10-24 | Resumed | Jefferies | Buy |
| Oct-23-24 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Aug-28-24 | Resumed | Evercore ISI | In-line |
| Jul-10-24 | Upgrade | Citigroup | Neutral → Buy |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Feb-07-24 | Upgrade | Jefferies | Hold → Buy |
| Jan-03-24 | Initiated | Barclays | Equal Weight |
| Dec-12-23 | Upgrade | BofA Securities | Neutral → Buy |
| Jun-29-23 | Initiated | Piper Sandler | Neutral |
| May-02-23 | Downgrade | BofA Securities | Buy → Neutral |
| Apr-03-23 | Upgrade | Citigroup | Sell → Neutral |
| Jan-23-23 | Initiated | Evercore ISI | In-line |
| Nov-17-22 | Downgrade | Citigroup | Neutral → Sell |
| Aug-22-22 | Resumed | Morgan Stanley | Equal-Weight |
| Apr-04-22 | Downgrade | Citigroup | Buy → Neutral |
| Feb-23-22 | Downgrade | UBS | Buy → Neutral |
| Feb-02-22 | Downgrade | Jefferies | Buy → Hold |
| Jan-28-22 | Downgrade | Deutsche Bank | Buy → Hold |
| May-04-21 | Upgrade | UBS | Neutral → Buy |
| Mar-12-21 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Oct-21-20 | Upgrade | Argus | Hold → Buy |
| Jul-29-20 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jul-14-20 | Upgrade | BofA Securities | Neutral → Buy |
| Jun-09-20 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Jun-02-20 | Upgrade | Deutsche Bank | Hold → Buy |
| Apr-28-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Apr-27-20 | Upgrade | Citigroup | Neutral → Buy |
| Apr-27-20 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| Mar-27-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-08-20 | Initiated | Wells Fargo | Underweight |
| Jan-07-20 | Downgrade | Barclays | Overweight → Equal Weight |
| Dec-19-19 | Upgrade | BofA/Merrill | Underperform → Neutral |
| Jul-15-19 | Downgrade | Goldman | Neutral → Sell |
| Apr-02-19 | Upgrade | Jefferies | Hold → Buy |
| Mar-18-19 | Resumed | Credit Suisse | Neutral |
| Jan-31-19 | Downgrade | Argus | Buy → Hold |
| Jan-17-19 | Initiated | UBS | Neutral |
| Jan-03-19 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Dec-03-18 | Downgrade | BofA/Merrill | Buy → Neutral |
| Nov-30-18 | Downgrade | Goldman | Buy → Neutral |
View All
Quest Diagnostics Inc Stock (DGX) Latest News
Quest Diagnostics stock holds near highs after Q2 beat - Ad-hoc-news.de
Is it the Right Time to Retain DGX Stock in Your Portfolio? - TradingView
Quest Diagnostics Incorporated (DGX) Hit a 52 Week High, Can the Run Continue? - Yahoo Finance
Trillium Asset Management LLC Takes $5.43 Million Position in Quest Diagnostics Incorporated $DGX - MarketBeat
SGL Investment Advisors Inc. Buys Shares of 27,290 Quest Diagnostics Incorporated $DGX - MarketBeat
Danske Bank A S Buys Shares of 68,561 Quest Diagnostics Incorporated $DGX - MarketBeat
5,500 Shares in Quest Diagnostics Incorporated $DGX Acquired by Glaxis Capital Management LLC - MarketBeat
Edmond DE Rothschild Holding S.A. Invests $944,000 in Quest Diagnostics Incorporated $DGX - MarketBeat
Ceredex Value Advisors LLC Makes New Investment in Quest Diagnostics Incorporated $DGX - MarketBeat
327,575 Shares in Quest Diagnostics Incorporated $DGX Bought by Advisors Capital Management LLC - MarketBeat
Quest Diagnostics Incorporated (NYSE:DGX) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Quest Diagnostics stock extends 2026 rally after Q2 revenue and earnings beat - Ad-hoc-news.de
Tocqueville Asset Management L.P. Takes $22.67 Million Position in Quest Diagnostics Incorporated $DGX - MarketBeat
Wealthfront Advisers LLC Makes New Investment in Quest Diagnostics Incorporated $DGX - MarketBeat
Deutsche Bank AG Makes New $124.18 Million Investment in Quest Diagnostics Incorporated $DGX - MarketBeat
BlackRock Inc. Makes New Investment in Quest Diagnostics Incorporated $DGX - MarketBeat
Quest Diagnostics Inc. stock outperforms competitors on strong trading day - MarketWatch
Quest Diagnostics stock hits a fresh high as Q2 earnings beat expectations - Ad-hoc-news.de
Quest Diagnostics stock hits all-time high at 240.15 USD - Investing.com
Quest Diagnostics stock hits all-time high at 240.15 USD By Investing.com - Investing.com Canada
M.D. Sass LLC Buys New Shares in Quest Diagnostics Incorporated $DGX - MarketBeat
Commerzbank Aktiengesellschaft FI Takes $1.42 Million Position in Quest Diagnostics Incorporated $DGX - MarketBeat
Foster & Motley Inc. Makes New $3.51 Million Investment in Quest Diagnostics Incorporated $DGX - MarketBeat
Danica Pension Livsforsikringsaktieselskab Invests $2.26 Million in Quest Diagnostics Incorporated $DGX - MarketBeat
Alpine Woods Capital Investors LLC Acquires New Position in Quest Diagnostics Incorporated $DGX - MarketBeat
Quest Diagnostics (DGX) Upgraded to Buy: Here's Why - Yahoo Finance
WHOOP opens blood tests to nonmembers and adds a test for signals tied to 50+ cancer types - Stock Titan
Nuance Investments LLC Takes Position in Quest Diagnostics Incorporated $DGX - MarketBeat
Occidental Asset Management LLC Invests $6.12 Million in Quest Diagnostics Incorporated $DGX - MarketBeat
Cornerstone Advisors LLC Invests $10.01 Million in Quest Diagnostics Incorporated $DGX - MarketBeat
GSA Capital Partners LLP Purchases Shares of 4,971 Quest Diagnostics Incorporated $DGX - MarketBeat
Quest Diagnostics (NYSE:DGX) Shows Dividend Quality Beyond the Headline Yield - ChartMill
Simplicity Wealth LLC Acquires New Position in Quest Diagnostics Incorporated $DGX - MarketBeat
J.Safra Asset Management Corp Purchases New Shares in Quest Diagnostics Incorporated $DGX - MarketBeat
ABN AMRO Bank N.V. Takes $21.52 Million Position in Quest Diagnostics Incorporated $DGX - MarketBeat
Carol Devine Miller sells stocks in Pfizer, Quest Diagnostics, Target, and U.S. Bancorp - Investing.com South Africa
Quest Diagnostics (DGX) Is Up 2.29% in One Week: What You Should Know - Yahoo Finance
T. Rowe Price Associates (DGX) discloses 5.43M Quest Diagnostics shares in 13G/A - Stock Titan
Assenagon Asset Management S.A. Acquires 4,334 Shares of Quest Diagnostics Incorporated $DGX - MarketBeat
Quest Diagnostics Incorporated (NYSE:DGX) Plans Quarterly Dividend of $0.86 - MarketBeat
Quest Diagnostics Inc (DGX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Q2 2026 Quest Diagnostics Inc Earnings Call Transcript - GuruFocus
Rep. Carol Miller's household sold Pfizer, Quest, Target, and U.S. Bancorp 521 days before disclosure - 24/7 Wall St.
Quest Diagnostics Keeps Quarterly Dividend at $0.86 per Share, Payable Oct. 21, to Shareholders of Record Oct. 6 - marketscreener.com
Quest Diagnostics Declares Quarterly Cash Dividend - marketscreener.com
Quest Diagnostics Sets Oct. 21 Date for Cash Dividend - Stock Titan
Diversified Management Inc. Lowers Holdings in Quest Diagnostics Incorporated $DGX - MarketBeat
IVY LANE CAPITAL MANAGEMENT, LLC's Quest Diagnostics Inc(DGX) Holding History - GuruFocus
Quest Diagnostics Incorporated $DGX Holdings Trimmed by Empowered Funds LLC - MarketBeat
Quest Diagnostics Inc (DGX) Stock News Today - TradingKey
Quest Diagnostics Inc (DGX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Quest Diagnostics Inc Stock (DGX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.58%
0.81%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):